Targeting multiple oncogenic pathways for the treatment of hepatocellular carcinoma

QR Code

Targeting multiple oncogenic pathways for the treatment of hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is one of the most common forms of liver cancer diagnosed worldwide. HCC occurs due to chronic liver disease and is often diagnosed at advanced stages. Chemotherapeutic agents such as doxorubicin are currently used as first-line agents for HCC therapy, but these are no...

Full description

Bibliographic Details
Main Authors:	Swamy, S., Kameshwar, V., Shubha, P., Looi, C., Shanmugam, M., Arfuso, Frank, Dharmarajan, Arunasalam, Sethi, Gautam, Shivananju, N., Bishayee, A.
Format:	Journal Article
Published:	2016
Online Access:	http://hdl.handle.net/20.500.11937/36646

Similar Items

Targeting the PI3K/Akt signaling pathway in gastric carcinoma: A reality for personalized medicine?
by: Singh, S., et al.
Published: (2015)

A novel benzimidazole derivative, MBIC inhibits tumor growth and promotes apoptosis via activation of ROS-dependent JNK signaling pathway in hepatocellular carcinoma
by: Dai, X., et al.
Published: (2017)

Dysregulation of Nrf2 in hepatocellular carcinoma: Role in cancer progression and chemoresistance
by: Raghunath, A., et al.
Published: (2018)

Wnt Signaling Pathway Related Genes In Hepatocellular Carcinoma
by: Ban, Kechen
Published: (2002)

Modulation of diverse oncogenic transcription factors by thymoquinone, an essential oil compound isolated from the seeds of Nigella sativa Linn
by: Shanmugam, M., et al.
Published: (2018)

Modulation of diverse oncogenic transcription factors by thymoquinone, an essential oil compound isolated from the seeds of Nigella sativa Linn
by: Shanmugam, M., et al.
Published: (2017)

Development of a novel azaspirane that targets the Janus Kinase-signal transducer and activator of transcription (STAT) pathway in hepatocellular carcinoma in vitro and in vivo
by: Mohan, C., et al.
Published: (2014)

Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma
by: Subramaniam, A., et al.
Published: (2012)

Hepatocellular Carcinoma
by: Tirnitz-Parker, Janine
Published: (2019)

Potential role of targeted therapies in the treatment of triple-negative breast cancer
by: Jia, L., et al.
Published: (2016)

N-substituted pyrido-1,4-Oxazin-3-ones induce apoptosis of hepatocellular carcinoma cells by targeting NF-kB signaling pathway
by: Mohan, C., et al.
Published: (2018)

Selenium and hepatocellular carcinoma
by: Nasar Alwahaibi,, et al.
Published: (2008)

Novel 1,3,4-oxadiazole induces anticancer activity by targeting NF-ÎºB in hepatocellular carcinoma cells
by: Mohan, C., et al.
Published: (2018)

Mouse Models of Hepatocellular Carcinoma
by: Carlessi, Rodrigo, et al.
Published: (2019)

γ-tocotrienol inhibits angiogenesis-dependent growth of human hepatocellular carcinoma through abrogation of AKT/mTOR pathway in an orthotopic mouse model
by: Siveen, K., et al.
Published: (2014)

γ-Tocotrienol is a novel inhibitor of constitutive and inducible STAT3 signalling pathway in human hepatocellular carcinoma: Potential role as an antiproliferative, pro-apoptotic and chemosensitizing agent
by: Rajendran, P., et al.
Published: (2011)

Ascochlorin enhances the sensitivity of doxorubicin leading to the reversal of epithelial-to-mesenchymal transition in hepatocellular carcinoma
by: Dai, X., et al.
Published: (2016)

Ascochlorin, an isoprenoid antibiotic inhibits growth and invasion of hepatocellular carcinoma by targeting STAT3 signaling cascade through the induction of PIAS3
by: Dai, X., et al.
Published: (2015)

Screening for hepatocellular carcinoma: patient selection and perspectives
by: Fateen, Waleed, et al.
Published: (2017)

Hepatocellular carcinoma with disseminated skeletal muscle metastasis
by: Abdul Rahim, Ezamin, et al.
Published: (2017)

Colon cancer chemoresistance and chemosensitization
by: Shanmugam, M., et al.
Published: (2018)

Emodin inhibits growth and induces apoptosis in an orthotopic hepatocellular carcinoma model by blocking activation of STAT3
by: Subramaniam, A., et al.
Published: (2013)

Suppression of signal transducer and activator of transcription 3 activation by butein inhibits growth of human hepatocellular carcinoma in vivo
by: Rajendran, P., et al.
Published: (2011)

Interplay of autophagy and cancer stem cells in hepatocellular carcinoma
by: Wong, M. M. T., et al.
Published: (2021)

Dynamics of the oncofetal ecosystem during Hepatocellular carcinoma evolution
by: Pai, Rhea Girish
Published: (2024)

Healthcare costs of transarterial chemoembolization in the treatment of hepatocellular carcinoma
by: Fateen, Waleed, et al.
Published: (2017)

Inhibition of STAT3 dimerization and acetylation by garcinol suppresses the growth of human hepatocellular carcinoma in vitro and in vivo
by: Sethi, G., et al.
Published: (2014)

Emodin suppresses migration and invasion through the modulation of CXCR4 expression in an orthotopic model of human hepatocellular carcinoma
by: Manu, K., et al.
Published: (2013)

Immune checkpoint inhibition: Prospects for prevention and therapy of hepatocellular carcinoma
by: Elsegood, Caryn, et al.
Published: (2017)

Liver progenitor cells, cancer stem cells and hepatocellular carcinoma
by: Tirnitz-Parker, Nina, et al.
Published: (2012)

Development and validation of an autoantibody-based blood test for hepatocellular carcinoma
by: Welberry, Christopher J.
Published: (2019)

Molecular modelling of berberine derivatives as inhibitors of oncogenic signalling pathways in breast cancer cell lines
by: Kaboli, Parham Jabbarzadeh
Published: (2017)

Targeting transcription factor STAT3 for cancer prevention and therapy.
by: Chai, E., et al.
Published: (2015)

Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1
by: Rajendran, P., et al.
Published: (2012)

Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors
by: Siveen, K., et al.
Published: (2013)

The leptin transduction pathway may be targeted against invasive ductal carcinoma of breast
by: M.Rahman, Shaikh, et al.
Published: (2018)

Development and application of the antigen microarray for the detection of autoantibodies in hepatocellular carcinoma patients
by: Afriyie-Asante, Afrakoma
Published: (2019)

Cytotoxicity of Goniothalamin on the Human Hepatocellular Carcinoma HEPG2 Cell Line
by: Obaid Al-Qubaisi, Mothanna Sadiq
Published: (2009)

Expression of interleukin-18, interferon-γ and interleukin-10 in hepatocellular carcinoma
by: Chia, Chok Seng, et al.
Published: (2002)

GSK-3β phosphorylation and alteration of β-catenin in hepatocellular carcinoma
by: Ban, Ke Chen, et al.
Published: (2003)

Cannot write session to /tmp/vufind_sessions/sess_gq0iu8iv6rlop46g1l1856cdv1